• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

44.74 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 224,820
Open 44.74
Bid (Size) 44.90 (300)
Ask (Size) 44.92 (100)
Prev. Close 44.74
Today's Range 44.74 - 44.74
52wk Range 35.12 - 81.44
Shares Outstanding N/A
Dividend Yield 5.70%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound? ↗
May 17, 2026
Promising clinical trial data suggests big opportunity with Eli Lilly's retatrutide GLP-1 candidate. 
Via The Motley Fool
News headline image
Buy, Sell, or Hold Novo Nordisk at $46? ↗
May 15, 2026
Can Novo Nordisk thrive under intense competitive pressures? 
Via The Motley Fool

Performance

YTD
-14.6%
-14.6%
1 Month
+10.4%
+10.4%
3 Month
-9.4%
-9.4%
6 Month
-7.7%
-7.7%
1 Year
-33.2%
-33.2%

More News

Read More
News headline image
2 Ways to Play the Big Pharma Patent Cliff ↗
May 15, 2026
Via MarketBeat
Topics ETFs Intellectual Property
News headline image
Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign? ↗
May 15, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Best Healthcare Stocks to Buy in 2026 ↗
May 14, 2026
Via The Motley Fool
News headline image
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within? ↗
May 14, 2026
Via The Motley Fool
News headline image
Is Novo Nordisk's Rebound for Real--or Just a Head Fake? ↗
May 13, 2026
Via The Motley Fool
News headline image
Novo Nordisk A/S Q1 Earnings Call Highlights ↗
May 13, 2026
Via MarketBeat
Topics Earnings
News headline image
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery? ↗
May 12, 2026
Via MarketBeat
Topics Intellectual Property Lawsuit
News headline image
Why Hims & Hers Health Stock Just Crashed ↗
May 12, 2026
Via The Motley Fool
Topics Earnings Lawsuit
News headline image
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
Via FinancialNewsMedia
News headline image
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
From MarketNewsUpdates.com
Via GlobeNewswire
BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly
May 11, 2026
Via Investor Brand Network
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026
Via Investor Brand Network
News headline image
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders? ↗
May 09, 2026
Via The Motley Fool
News headline image
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026
From BioMedWire
Via GlobeNewswire
News headline image
Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus ↗
May 08, 2026
Via MarketBeat
News headline image
Forget Eli Lilly: These 2 Stocks Have More Upside ↗
May 07, 2026
Via The Motley Fool
News headline image
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims ↗
May 07, 2026
Via MarketBeat
News headline image
My Top Obesity Stock to Buy and Hold ↗
May 07, 2026
Via The Motley Fool
Record Highs, Punished Results, and One Very Consequential Apple Rumor ↗
May 06, 2026
Via Chartmill
News headline image
3 Absurdly Cheap Growth Stocks to Buy in May 2026 ↗
May 04, 2026
Via The Motley Fool
News headline image
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months ↗
May 04, 2026
Via The Motley Fool
News headline image
Eli Lilly Just Announced Fantastic News for Shareholders ↗
May 04, 2026
Via The Motley Fool
Topics Earnings
News headline image
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026) ↗
May 02, 2026
Via The Motley Fool

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 44.74
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 05/15/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap